HealthTree

Your Feed

Filter by

See content from

Back to the latest

Assessing Responses of High-Risk CLL Patients to New Combo Therapy

Posted by

HealthTree

Assessing Responses of High-Risk CLL Patients to New Combo Therapy image

Read article

Learn How you Can Volunteer with the HealthTree Regional Cure Teams

Feb 13, 2025

12:00PM - 01:00PM EST

Watch Recording

What are the Recent Updates on BTK Degraders for CLL/SLL?

Posted by

HealthTree

What are the Recent Updates on BTK Degraders for CLL/SLL? image

Read article

MariaJ • Admin

Chronic Lymphocytic Leukemia Discussion • February 10, 2025

Navigating CLL Treatment: New Patient Guide

AI-generated title

🎉 Exciting news, HealthTree community! We've just launched our newest resource to help you navigate CLL treatment decisions. This guide was created WITH patients, FOR patients, and includes real experiences from our community members alongside expert medical information. Check it out and let us know what you think! https://bit.ly/4humgxr

Introduction to CLL Treatment Guide - HealthTree for Chronic Lymphocytic Leukemia

In this section, you will learn about the purpose of this guide, how to navigate it, and what you will need to search for elsewhere.

https://bit.ly/4humgxr

How Chronic Lymphocytic Leukemia Weakens Your Immune System: What You Need to Know

Feb 07, 2025

03:00PM - 04:00PM EST

Watch Recording

Bi-Monthly Blood Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions

Feb 04, 2025

01:00PM - 02:00PM EST

Watch Recording

HealthTree Foundation Honors Leading Blood Cancer Researchers at ASH 2024 Awards Reception

Posted by

HealthTree

Read article

An Opportunity to Take Action: Regional Cure Teams

Posted by

HealthTree

An Opportunity to Take Action: Regional Cure Teams image

Read article

Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients

Posted by

HealthTree

Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients image

Read article

Astonishing Reversal on Cancer Research Funding Freeze

Posted by

HealthTree

Astonishing Reversal on Cancer Research Funding Freeze image

Read article

The Iron Survivor: Chronic Lymphocytic Leukemia Patient Spotlight Pratik Desai

Jan 17, 2025

07:00PM - 08:00PM EST

Watch Recording

Want a Better Understanding of CLL Treatments? Start Here: CLL Therapy Guide

Posted by

HealthTree

Want a Better Understanding of CLL Treatments? Start Here: CLL Therapy Guide image

Read article

Changes in ACA and Medicaid: What You Need to Know and How to Prepare

Posted by

HealthTree

Changes in ACA and Medicaid: What You Need to Know and How to Prepare image

Read article

CLL Specialists' Strategies for Side Effect Management and Third-Line Treatments

Posted by

HealthTree

CLL Specialists' Strategies for Side Effect Management and Third-Line Treatments image

Read article

ACA Changes and Medicaid Expansion: What Blood Cancer Patients Need to Know and How to Stay Prepared

Jan 07, 2025

01:00PM - 02:00PM EST

Watch Recording

Playlist: ASH 2024

BTK Degrader Study Shows Promise for a New Class of CLL Therapies | Alexey Danilov MD PhD | #ASH2024

Video details & playlist

Playlist: ASH 2024

Duration of BTKi therapy correlates with time to next treatment in CLL | Kerry Rogers, MD | #ASH24

Video details & playlist

CLL Expert Insights on Choosing Treatment and BTK + BCL-2i Combos

Posted by

HealthTree

CLL Expert Insights on Choosing Treatment and BTK + BCL-2i Combos image

Read article

Holiday Infection Prevention Guide for Blood Cancer Patients

Posted by

HealthTree

Holiday Infection Prevention Guide for Blood Cancer Patients image

Read article

Epcoritamab as Single Therapy for Relapsed/Refractory CLL/SLL

A Unique BTK Inhibitor, Pirtobrutinib for Patients with Pretreated CLL | Jeff Sharman, MD | #ASH24

Video details & playlist

Playlist: ASH 2024

Duvelisib + Venetoclax: A Time-Limited, All Oral Option for CLL | Jennifer Crombie, MD | #ASH24

Video details & playlist

Playlist: CLL Basics 3

Major side effects of CLL: what patients should prepare for

Video details & playlist

A Fixed-Duration Regimen for CLL: Acalabrutinib + Venetoclax Results from the AMPLIFY Trial

Posted by

HealthTree

A Fixed-Duration Regimen for CLL: Acalabrutinib + Venetoclax Results from the AMPLIFY Trial image

Read article